Article Text

Download PDFPDF
Comparative analysis of the prevalence 3-HIT concept in people living with HIV and seronegative patients with chronic conditions. Cross-3HIT Project.
  1. Enrique Contreras Macías1,
  2. Juan Miguel Espina Lozano2,
  3. Maria Dolores Cantudo-Cuenca2,
  4. Maria de las Aguas Robustillo-Cortés2,
  5. Estefanía Gabella-Bazarot2,
  6. Ramón Morillo-Verdugo2
    1. 1Hospital Pharmacy, Hospital San Juan De Dios De Sevilla, Sevilla, Andalucía, Spain
    2. 2Hospital Universitario Virgen de Valme, Sevilla, Spain
    1. Correspondence to Dr Juan Miguel Espina Lozano, Hospital Universitario Virgen de Valme, Sevilla, Spain; Juanmii96{at}gmail.com

    Abstract

    Objectives This study aimed to assess and compare the occurrence of 3-HIT in people living with HIV (PLWH) and seronegative patients. Additionally, the study investigated whether HIV infection could serve as a predictor of the presence of 3-HIT.

    Methods A cross-sectional study was conducted between December 2022 and January 2023 to compare PLWH with a group of seronegative patients with chronic diseases attending an outpatient hospital pharmacy service. The 3-HIT concept encompasses the simultaneous presence of non-adherence to concomitant treatment (NAC), drug–drug interactions (DDIs), and high pharmacotherapeutic complexity in polymedicated patients. The assessment of 3-HIT compliance included NAC, evaluated using both the Morisky-Green questionnaire and electronic pharmacy dispensing records. DDIs were analysed using the Liverpool University and Micromedex databases. Pharmacotherapeutic complexity was measured using the Medication Regimen Complexity Index (MRCI) tool. Logistic regression analysis was performed to identify independent factors related to 3-HIT. Additionally, an explanatory logistic model was created to investigate whether HIV infection, along with other adjustment variables, could predict compliance with the 3-HIT concept.

    Results The study included 145 patients: 75 PLWH and 70 seronegative patients. The median age was 40 versus 39 years, respectively (p=0.22). Seronegative patients exhibited a higher prevalence of NAC (p<0.01). HIV infection was identified as a protective factor in the context of DDIs (p<0.01). Male sex (p<0.01) and age (p=0.01) were identified as being associated with an MRCI ≥11.25 points. A higher prevalence of 3-HIT was observed in seronegative patients (18.7% vs 48.6%, p<0.01). However, the developed regression model identified HIV infection as a risk factor associated with an increased likelihood of 3-HIT (OR 4.00, 95% CI 1.88 to 8.52, p<0.01).

    Conclusions The 3-HIT concept exhibited a high prevalence among seronegative patients with chronic diseases, with HIV infection identified as a predicted risk factor for NAC and the development of 3-HIT.

    • HIV
    • DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS
    • Quality of Health Care
    • PHARMACY SERVICE, HOSPITAL
    • EDUCATION, PHARMACY

    Data availability statement

    Data are available upon reasonable request. Study data are available upon reasonable request.

    Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Data availability statement

    Data are available upon reasonable request. Study data are available upon reasonable request.

    View Full Text